Drawing for CHIRABOT

USPTO serial 87720078

CHIRABOT

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
ATTANG, UDEME U
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CHIRABOT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
009Robotic exoskeleton suits worn by humans for the purpose of enhancing the strength and endurance of the person wearing the suitACTIVE—
010Robotic arms for use by mobility-impaired individuals; Electrical stimulation apparatus for causing movement of body parts for locomotion and exercise purposes; Electromedical rehabilitative and pain management products for clinical and home use, namely, electrical nerve and muscle stimulators, ultrasonic stimulators, magnet therapy stimulators and laser therapy stimulators; Electronic muscle stimulators for medical purposes; Electrotherapy stimulation apparatus comprising electrical nerve and muscle stimulators, contained within skin-tight clothing for use with external control of body motion; Medical device, namely, a tele-robotic system consisting of a motorized catheter positioner having rotational and translational movement capability and a tele-robotic controller with rotation, translation and deflection control buttons, to facilitate remote catheterizations; Medical devices, namely, pulse generators for stimulating movements of the bodyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Feb 4, 2019MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 4, 2019ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 3, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 8, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 8, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 18, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 1, 2018ALIEASSIGNED TO LIE—
Mar 26, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 26, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Mar 26, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 26, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 26, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 23, 2018DOCKASSIGNED TO EXAMINER—
Dec 27, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 16, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance